Jpmorgan Chase & CO Mimedx Group, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MDXG
# of Institutions
222Shares Held
96.2MCall Options Held
115KPut Options Held
189K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$201 Million63.89% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$66.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.93MShares$49.4 Million0.0% of portfolio
-
Trigran Investments, Inc.4.48MShares$31.9 Million3.25% of portfolio
-
Paradigm Capital Management Inc4.17MShares$29.7 Million1.33% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $810M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...